Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317892856> ?p ?o ?g. }
- W4317892856 endingPage "471" @default.
- W4317892856 startingPage "453" @default.
- W4317892856 abstract "Non-ST-segment elevation acute coronary syndromes (NSTE-ACS), including non-ST-segment-elevation myocardial infarction (NSTEMI) and unstable angina, represent a leading cause of mortality worldwide, with important socio-economic consequences. NSTEMI accounts for the majority of acute coronary syndromes and usually develops on the background of a nonocclusive thrombus. We searched for relevant literature in the field in PubMed and clinicaltrials.gov as of July 2022.A number of pharmacotherapies are currently available for treatment and secondary prevention, mainly including antithrombotic, lipid-lowering and anti-inflammatory drugs. Pretreatment with aspirin, anticoagulant and statin therapy is of key importance in the preprocedural phase, while pretreating with an oral P2Y12 inhibitor is not routinely indicated in patients undergoing early invasive management. For patients undergoing percutaneous coronary revascularization, pharmacotherapy essentially consists of antithrombotic drugs, which should be carefully selected. Finally, antithrombotic, lipid-lowering and anti-inflammatory drugs are important components of long-term secondary prevention after a NSTE-ACS.This article reviews the evidence supporting recommendation on pharmacotherapy in patients presenting with a NSTE-ACS. Several randomized clinical trials are still ongoing and are expected to further inform scientific knowledge and clinical practice, with the final aim to improve the treatment of NSTE-ACS patients." @default.
- W4317892856 created "2023-01-25" @default.
- W4317892856 creator A5040418600 @default.
- W4317892856 creator A5048882118 @default.
- W4317892856 creator A5078233605 @default.
- W4317892856 creator A5087550320 @default.
- W4317892856 date "2023-02-07" @default.
- W4317892856 modified "2023-10-11" @default.
- W4317892856 title "Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation" @default.
- W4317892856 cites W1520609538 @default.
- W4317892856 cites W1563829853 @default.
- W4317892856 cites W1569796594 @default.
- W4317892856 cites W1936983670 @default.
- W4317892856 cites W194894827 @default.
- W4317892856 cites W1993538889 @default.
- W4317892856 cites W201549064 @default.
- W4317892856 cites W2022506351 @default.
- W4317892856 cites W2053379248 @default.
- W4317892856 cites W2059215195 @default.
- W4317892856 cites W2065390746 @default.
- W4317892856 cites W2071686230 @default.
- W4317892856 cites W2076416344 @default.
- W4317892856 cites W2081613030 @default.
- W4317892856 cites W2084673482 @default.
- W4317892856 cites W2095901832 @default.
- W4317892856 cites W2103798714 @default.
- W4317892856 cites W21063540 @default.
- W4317892856 cites W2113978145 @default.
- W4317892856 cites W2117559770 @default.
- W4317892856 cites W2117677020 @default.
- W4317892856 cites W2123112974 @default.
- W4317892856 cites W2125173296 @default.
- W4317892856 cites W2136228924 @default.
- W4317892856 cites W2140501627 @default.
- W4317892856 cites W2141358924 @default.
- W4317892856 cites W2147270034 @default.
- W4317892856 cites W2150655309 @default.
- W4317892856 cites W2153107785 @default.
- W4317892856 cites W2156496314 @default.
- W4317892856 cites W2159370853 @default.
- W4317892856 cites W2160152341 @default.
- W4317892856 cites W2169387542 @default.
- W4317892856 cites W2219664444 @default.
- W4317892856 cites W2251546558 @default.
- W4317892856 cites W2339906403 @default.
- W4317892856 cites W2396902189 @default.
- W4317892856 cites W2509918966 @default.
- W4317892856 cites W2556417520 @default.
- W4317892856 cites W2584407743 @default.
- W4317892856 cites W2596179513 @default.
- W4317892856 cites W2614154720 @default.
- W4317892856 cites W2647552175 @default.
- W4317892856 cites W2748400555 @default.
- W4317892856 cites W2748517697 @default.
- W4317892856 cites W2749380187 @default.
- W4317892856 cites W2749929702 @default.
- W4317892856 cites W2767660506 @default.
- W4317892856 cites W2781493959 @default.
- W4317892856 cites W2790531075 @default.
- W4317892856 cites W2792735509 @default.
- W4317892856 cites W2798205550 @default.
- W4317892856 cites W2809722890 @default.
- W4317892856 cites W2888458270 @default.
- W4317892856 cites W2893951801 @default.
- W4317892856 cites W2894569178 @default.
- W4317892856 cites W2899997727 @default.
- W4317892856 cites W2907026484 @default.
- W4317892856 cites W2915284549 @default.
- W4317892856 cites W2921724943 @default.
- W4317892856 cites W2922038538 @default.
- W4317892856 cites W2945293819 @default.
- W4317892856 cites W2953479758 @default.
- W4317892856 cites W2955952534 @default.
- W4317892856 cites W2971165578 @default.
- W4317892856 cites W2972299172 @default.
- W4317892856 cites W2973068166 @default.
- W4317892856 cites W2976166882 @default.
- W4317892856 cites W2982456693 @default.
- W4317892856 cites W2982475069 @default.
- W4317892856 cites W2986700515 @default.
- W4317892856 cites W2987850771 @default.
- W4317892856 cites W2996361566 @default.
- W4317892856 cites W2996690836 @default.
- W4317892856 cites W2999002463 @default.
- W4317892856 cites W3008285545 @default.
- W4317892856 cites W3012265841 @default.
- W4317892856 cites W3016343127 @default.
- W4317892856 cites W3028115716 @default.
- W4317892856 cites W3030446357 @default.
- W4317892856 cites W3035351100 @default.
- W4317892856 cites W3039015991 @default.
- W4317892856 cites W3046237006 @default.
- W4317892856 cites W3081761942 @default.
- W4317892856 cites W3081991699 @default.
- W4317892856 cites W3082109297 @default.
- W4317892856 cites W3082881918 @default.
- W4317892856 cites W3092669347 @default.
- W4317892856 cites W3105723579 @default.